LS
INSM icon

Livforsakringsbolaget Skandia’s Insmed INSM Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470K Buy
4,412
+2,912
+194% +$448K 0.02% 226
2025
Q4 		$261K Buy
+1,500
New +$274K 0.01% 296

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Livforsakringsbolaget Skandia's INSM Position: Q1 2026 in Review

Livforsakringsbolaget Skandia increased its Insmed (INSM) stake by 194% in Q1 2026, buying an estimated $448K and bringing the position to 4,412 shares worth $470K. The position accounts for 0.02% of the portfolio, ranked #226.

Livforsakringsbolaget Skandia first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Livforsakringsbolaget Skandia held 4,412 shares of Insmed worth $470K as of Q1 2026.
  • Livforsakringsbolaget Skandia bought 2,912 Insmed shares in Q1 2026, an estimated $448K.
  • Insmed made up 0.02% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #226 holding.
  • Livforsakringsbolaget Skandia first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.